CGT
FBT icon

Capital Guardian Trust’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Capital Guardian Trust’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-614
Closed -$42K – 516
2013
Q4 		$42K Buy
+614
New +$40.3K ﹤0.01% 384

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Capital Guardian Trust's FBT Position: Q1 2014 in Review

Capital Guardian Trust sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2014, closing a stake of 614 shares — an estimated $42K sold.

Capital Guardian Trust first reported a position in FBT in Q4 2013 and held it in 1 quarter. The position peaked at $42K in Q4 2013. 84 funds tracked by Wall St. Rank hold FBT as of Q1 2014.

  • Capital Guardian Trust reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2014 after selling out during the quarter.
  • Capital Guardian Trust sold 614 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2014, an estimated $42K.
  • Capital Guardian Trust first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and held it in 1 quarter.
  • Capital Guardian Trust's First Trust NYSE Arca Biotechnology Index Fund position peaked at $42K in Q4 2013.
  • 84 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2014.

Based on Capital Guardian Trust's 13F filing for Q1 2014, filed 15 May 2014.